# Ciprofloxacin Multiple Dose for Adult Cholera

> **NCT00741052** · PHASE3 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 218 (estimated)

## Conditions studied

- Cholera

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00741052
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-10
- **Final completion:** 2010-06
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2011-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741052, "Ciprofloxacin Multiple Dose for Adult Cholera". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00741052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*